Seltene Erkrankungen des Larynx, der Trachea und der
                    Schilddrüse

Stephan Hackenberg; Fabian Kraus; Agmal Scherzad

doi:10.1055/a-1337-5703

Laryngo-Rhino-Otologie, Inhaltsverzeichnis

CC BY-NC-ND 4.0 · Laryngorhinootologie 2021; 100(S 01): S1-S36
DOI: 10.1055/a-1337-5703

Referat

Rare Diseases of Larynx, Trachea and Thyroid

Artikel in mehreren Sprachen: deutsch | English

Autor*innen

Stephan Hackenberg

¹Klinik und Poliklinik für Hals-, Nasen- und Ohrenkrankheiten, plastische und ästhetische Operationen, Universitätsklinikum Würzburg
Fabian Kraus

¹Klinik und Poliklinik für Hals-, Nasen- und Ohrenkrankheiten, plastische und ästhetische Operationen, Universitätsklinikum Würzburg
Agmal Scherzad

¹Klinik und Poliklinik für Hals-, Nasen- und Ohrenkrankheiten, plastische und ästhetische Operationen, Universitätsklinikum Würzburg

Abstract

This review article covers data on rare diseases of the larynx, the trachea and the thyroid. In particular, congenital malformations, rare manifestations of inflammatory laryngeal disorders, benign and malignant epithelial as well as non-epithelial tumors, laryngeal and tracheal manifestations of general diseases and, finally, thyroid disorders are discussed. The individual chapters contain an overview of the data situation in the literature, the clinical appearance of each disorder, important key points for diagnosis and therapy and a statement on the prognosis of the disease. Finally, the authors indicate on study registers and self-help groups.

Key words

rare disease - larynx - trachea - thyroid

Volltext

Referenzen

Literatur
1 Holinger LD. Etiology of Stridor in the Neonate, Infant and Child. Ann Oto Rhinol Laryn 1980; 89: 397-400
2 Friedman EM, Vastola AP, Mcgill TJI. et al. Chronic Pediatric Stridor – Etiology and Outcome. Laryngoscope 1990; 100: 277-280
3 Zoumalan R, Maddalozzo J, Holinger LD. Etiology of stridor in infants. Ann Oto Rhinol Laryn 2007; 116: 329-334
4 Hoff SR, Schroeder JW, Rastatter JC. et al. Supraglottoplasty outcomes in relation to age and comorbid conditions. Int J Pediatr Otorhi 2010; 74: 245-249
5 Krashin E, Ben-Ari J, Springer C. et al. Synchronous airway lesions in laryngomalacia. Int J Pediatr Otorhi 2008; 72: 501-507
6 Schroeder JW, Bhandarkar ND, Holinger LD. Synchronous Airway Lesions and Outcomes in Infants With Severe Laryngomalacia Requiring Supraglottoplasty. Arch Otolaryngol 2009; 135: 647-651
7 Yuen HW, Tan HKK, Balakrishnan A. Synchronous airway lesions and associated anomalies in children with laryngomalacia evaluated with rigid endoscopy. Int J Pediatr Otorhi 2006; 70: 1779-1784
8 Olney DR, Greinwald JH, Smith RJH. et al. Laryngomalacia and its treatment. Laryngoscope 1999; 109: 1770-1775
9 Koitschev A, Sittel C. Laryngomalacia. When does surgery make sense?. HNO 2012; 60: 573-580
10 Sittel C. Pathologies of the larynx and trachea in childhood. Laryngorhinootologie 2014; 93: S70-S83
11 Werner JA, Lippert BM, Dunne AA. et al. Epiglottopexy for the treatment of severe laryngomalacia. Eur Arch Otorhinolaryngol 2002; 259: 459-464
12 Denoyelle F, Mondain M, Gresillon N. et al. Failures and complications of supraglottoplasty in children. Arch Otolaryngol Head Neck Surg 2003; 129: 1077-1080 discussion 1080
13 Toynton SC, Saunders MW, Bailey CM. Aryepiglottoplasty for laryngomalacia: 100 consecutive cases. J Laryngol Otol 2001; 115: 35-38
14 Sittel C, Monnier P, Peretti G. et al. Prognostic value of the ELS grading system for assessment of laryngotracheal stenosis in children. HNO 2020; 68: 407-413
15 Miyamoto RC, Parikh SR, Gellad W. et al. Bilateral congenital vocal cord paralysis: a 16-year institutional review. Otolaryngol Head Neck Surg 2005; 133: 241-245
16 Murty GE, Shinkwin C, Gibbin KP. Bilateral Vocal Fold Paralysis in Infants – Tracheostomy or Not. Journal of Laryngology and Otology 1994; 108: 329-331
17 Cohen SR, Geller KA, Birns JW. et al. Laryngeal paralysis in children: a long-term retrospective study. Ann Otol Rhinol Laryngol 1982; 91: 417-424
18 de Gaudemar I, Roudaire M, Francois M. et al. Outcome of laryngeal paralysis in neonates: a long term retrospective study of 113 cases. Int J Pediatr Otorhinolaryngol 1996; 34: 101-110
19 Daya H, Hosni A, Bejar-Solar I. et al. Pediatric vocal fold paralysis: a long-term retrospective study. Arch Otolaryngol Head Neck Surg 2000; 126: 21-25
20 Gentile RD, Miller RH, Woodson GE. Vocal cord paralysis in children 1 year of age and younger. Ann Otol Rhinol Laryngol 1986; 95: 622-625
21 Emery PJ, Fearon B. Vocal cord palsy in pediatric practice: a review of 71 cases. Int J Pediatr Otorhinolaryngol 1984; 8: 147-154
22 Zbar RI, Smith RJ. Vocal fold paralysis in infants twelve months of age and younger. Otolaryngol Head Neck Surg 1996; 114: 18-21
23 Berkowitz RG. Natural history of tracheostomy-dependent idiopathic congenital bilateral vocal fold paralysis. Otolaryngol Head Neck Surg 2007; 136: 649-652
24 Ruf K, Hackenberg S, Kraus F. et al. Carbon Dioxide Laser Cordotomy as Possible Alternative for Tracheotomy in a Neonate with Idiopathic Bilateral Vocal Fold Paralysis. Klin Padiatr 2016; 228: 213-215
25 Richter C. Dissertatio médico de infanticide inartis obstetriciae: Thesis for Doctor of Medicine. Leipzig; 1792
26 Roth B, Rose KG, Benzbohm G. et al. Laryngo-Tracheo-Esophageal Cleft – Clinical-Features, Diagnosis and Therapy. Eur J Pediatr 1983; 140: 41-46
27 Delahunty JE, Cherry J. Congenital Larygeal Cleft. Ann Oto Rhinol Laryn 1969; 78: 96-+
28 Watters K, Russell J. Diagnosis and management of type 1 laryngeal cleft. Int J Pediatr Otorhinolaryngol 2003; 67: 591-596
29 Rahbar R, Rouillon I, Roger G. et al. The presentation and management of laryngeal cleft: a 10-year experience. Arch Otolaryngol Head Neck Surg 2006; 132: 1335-1341
30 Rahbar R, Chen JL, Rosen RL. et al. Endoscopic repair of laryngeal cleft type I and type II: when and why?. Laryngoscope 2009; 119: 1797-1802
31 Benjamin B, Inglis A. Minor congenital laryngeal clefts: diagnosis and classification. Ann Otol Rhinol Laryngol 1989; 98: 417-420
32 Johnston DR, Watters K, Ferrari LR. et al. Laryngeal cleft: evaluation and management. Int J Pediatr Otorhinolaryngol 2014; 78: 905-911
33 Chien W, Ashland J, Haver K. et al. Type 1 laryngeal cleft: establishing a functional diagnostic and management algorithm. Int J Pediatr Otorhinolaryngol 2006; 70: 2073-2079
34 Sandu K, Monnier P. Endoscopic laryngotracheal cleft repair without tracheotomy or intubation. Laryngoscope 2006; 116: 630-634
35 Garabedian EN, Pezzettigotta S, Leboulanger N. et al. Endoscopic surgical treatment of laryngotracheal clefts: indications and limitations. Arch Otolaryngol Head Neck Surg 2010; 136: 70-74
36 Parsons DS, Stivers FE, Giovanetto DR. et al. Type I posterior laryngeal clefts. Laryngoscope 1998; 108: 403-410
37 van der Doef HP, Yntema JB, van den Hoogen FJ. et al. Clinical aspects of type 1 posterior laryngeal clefts: literature review and a report of 31 patients. Laryngoscope 2007; 117: 859-863
38 Kawaguchi AL, Donahoe PK, Ryan DP. Management and long-term follow-up of patients with types III and IV laryngotracheoesophageal clefts. J Pediatr Surg 2005; 40: 158-164. discussion 164–155
39 Ryan DP, Muehrcke DD, Doody DP. et al. Laryngotracheoesophageal cleft (type IV): management and repair of lesions beyond the carina. J Pediatr Surg 1991; 26: 962-969. discussion 969–970
40 Mathur NN, Peek GJ, Bailey CM. et al. Strategies for managing Type IV laryngotracheoesophageal clefts at Great Ormond Street Hospital for Children. Int J Pediatr Otorhinolaryngol 2006; 70: 1901-1910
41 Geller K, Kim Y, Koempel J. et al. Surgical management of type III and IV laryngotracheoesophageal clefts: the three-layered approach. Int J Pediatr Otorhinolaryngol 2010; 74: 652-657
42 Crisera CA, Grau JB, Maldonado TS. et al. Defective epithelial-mesenchymal interactions dictate the organogenesis of tracheoesophageal fistula. Pediatr Surg Int 2000; 16: 256-261
43 Crisera CA, Connelly PR, Marmureanu AR. et al. Esophageal atresia with tracheoesophageal fistula: suggested mechanism in faulty organogenesis. J Pediatr Surg 1999; 34: 204-208
44 Billmyre KK, Hutson M, Klingensmith J. One shall become two: Separation of the esophagus and trachea from the common foregut tube. Dev Dyn 2015; 244: 277-288
45 Cassina M, Ruol M, Pertile R. et al. Prevalence, characteristics, and survival of children with esophageal atresia: A 32-year population-based study including 1,417,724 consecutive newborns. Birth Defects Res A Clin Mol Teratol 2016; 106: 542-548
46 Muensterer OJ, Berdon WE. From Vogt to Haight and Holt to now: the history of esophageal atresia over the last century. Pediatr Radiol 2015; 45: 1230-1235
47 Parolini F, Morandi A, Macchini F. et al. Esophageal atresia with proximal tracheoesophageal fistula: A missed diagnosis. Journal of Pediatric Surgery 2013; 48: E13-E17
48 Pretorius DH, Drose JA, Dennis MA. et al. Tracheoesophageal fistula in utero. Twenty-two cases. J Ultrasound Med 1987; 6: 509-513
49 Karnak I, Senocak ME, Hicsonmez A. et al. The diagnosis and treatment of H-type tracheoesophageal fistula. J Pediatr Surg 1997; 32: 1670-1674
50 Salik I, Paul M. Tracheoesophageal Fistula. In StatPearls. Treasure Island (FL): 2020
51 Sparey C, Jawaheer G, Barrett AM. et al. Esophageal atresia in the Northern Region Congenital Anomaly Survey, 1985-1997: prenatal diagnosis and outcome. Am J Obstet Gynecol 2000; 182: 427-431
52 Rothenberg SS. Thoracoscopic repair of esophageal atresia and tracheo-esophageal fistula. Semin Pediatr Surg 2005; 14: 2-7
53 Rothenberg SS. Thoracoscopic repair of esophageal atresia and tracheo-esophageal fistula in neonates: evolution of a technique. J Laparoendosc Adv Surg Tech A 2012; 22: 195-199
54 Holinger PH, Brown WT. Congenital webs, cysts, laryngoceles and other anomalies of the larynx. Ann Otol Rhinol Laryngol 1967; 76: 744-752
55 Nicollas R, Triglia JM. The anterior laryngeal webs. Otolaryngol Clin North Am 2008; 41: 877-888 viii
56 Miyamoto RC, Cotton RT, Rope AF. et al. Association of anterior glottic webs with velocardiofacial syndrome (chromosome 22q11.2 deletion). Otolaryngol Head Neck Surg 2004; 130: 415-417
57 Lim FY, Crombleholme TM, Hedrick HL. et al. Congenital high airway obstruction syndrome: natural history and management. J Pediatr Surg 2003; 38: 940-945
58 Lawlor CM, Dombrowski ND, Nuss RC. et al. Laryngeal Web in the Pediatric Population: Evaluation and Management. Otolaryngol Head Neck Surg 2020; 162: 234-240
59 Rodriguez H, Cuestas G, Zanetta A. Dysphonia in children due to congenital laryngeal web. Case series. Arch Argent Pediatr 2013; 111: E82-E85
60 Wyatt ME, Hartley BEJ. Laryngotracheal reconstruction in congenital laryngeal webs and atresias. Otolaryng Head Neck 2005; 132: 232-238
61 de Trey LA, Lambercy K, Monnier P. et al. Management of severe congenital laryngeal webs – a 12 year review. Int J Pediatr Otorhinolaryngol 2016; 86: 82-86
62 Schummer W, Schummer C, Klemm P. et al. Tracheal agenesis. A rare cause of respiratory insufficiency in neonates. Anaesthesist 2006; 55: 1259-1265
63 Floyd J, Campbell DC, Dominy DE. Agenesis of the trachea. Am Rev Respir Dis 1962; 86: 557-560
64 Varela P, Torre M, Schweiger C. et al. Congenital tracheal malformations. Pediatr Surg Int 2018; 34: 701-713
65 Smith MM, Huang A, Labbe M. et al. Clinical presentation and airway management of tracheal atresia: A systematic review. Int J Pediatr Otorhinolaryngol 2017; 101: 57-64
66 Kalache KD, Chaoui R, Bollmann R. Doppler assessment of tracheal and nasal fluid flow during fetal breathing movements: preliminary observations. Ultrasound Obstet Gynecol 1997; 9: 257-261
67 Seifert GJNuN. Rachen und Tonsillen, Ohr, Larynx. Berlin, Heidelberg, New York: HNO-Pathologie; 1999. DOI 67-68
68 Lahav G, Lahav Y, Ciobotaro P. et al. Laryngeal Syphilis A Case Report. Arch Otolaryngol 2011; 137: 294-297
69 Singh B, Balwally AN, Nash M. et al. Laryngeal tuberculosis in HIV-infected patients: A difficult diagnosis. Laryngoscope 1996; 106: 1238-1240
70 Wang CC, Lin CC, Wang CP. et al. Laryngeal tuberculosis: A review of 26 cases. Otolaryng Head Neck 2007; 137: 582-588
71 Lim JY, Kim KM, Choi EC. et al. Current clinical propensity of laryngeal tuberculosis: review of 60 cases. Eur Arch Oto-Rhino-L 2006; 263: 838-842
72 Agarwal R, Gupta L, Singh M. et al. Primary Laryngeal Tuberculosis: A Series of 15 Cases. Head Neck Pathol 2019; 13: 339-343
73 Bailey CM, Windletaylor PC. Tuberculous Laryngitis – a Series of 37 Patients. Laryngoscope 1981; 91: 93-100
74 Swain SK, Behera IC, Sahu MC. Primary Laryngeal Tuberculosis: Our Experiences at a Tertiary Care Teaching Hospital in Eastern India. J Voice 2019; 33: 812, e819-812, e814
75 Wang CC, Lin CC, Wang CP. et al. Laryngeal tuberculosis: a review of 26 cases. Otolaryngol Head Neck Surg 2007; 137: 582-588
76 Soni NK. Leprosy of the larynx. J Laryngol Otol 1992; 106: 518-520
77 Moraes BT, Filho Fde S, Neto JC. et al. Laryngeal leishmaniasis. Int Arch Otorhinolaryngol 2012; 16: 523-526
78 Grant A, Spraggs PD, Grant HR. et al. Laryngeal leishmaniasis. J Laryngol Otol 1994; 108: 1086-1088
79 Guerra JAD, Prestes SR, Silveira H. et al. Mucosal Leishmaniasis Caused by Leishmania (Viannia) braziliensis and Leishmania (Viannia) guyanensis in the Brazilian Amazon. Plos Neglect Trop D 2011; 5
80 Herwaldt BL. Leishmaniasis. Lancet 1999; 354: 1191-1199
81 Derkay CS, Wiatrak B. Recurrent respiratory papillomatosis: a review. Laryngoscope 2008; 118: 1236-1247
82 Larson DA, Derkay CS. Epidemiology of recurrent respiratory papillomatosis. APMIS 2010; 118: 450-454
83 Rabah R, Lancaster WD, Thomas R. et al. Human papillomavirus-11-associated recurrent respiratory papillomatosis is more aggressive than human papillomavirus-6-associated disease. Pediatr Dev Pathol 2001; 4: 68-72
84 Rodier C, Lapointe A, Coutlee F. et al. Juvenile respiratory papillomatosis: risk factors for severity. J Med Virol 2013; 85: 1447-1458
85 Silver RD, Rimell FL, Adams GL. et al. Diagnosis and management of pulmonary metastasis from recurrent respiratory papillomatosis. Otolaryngol Head Neck Surg 2003; 129: 622-629
86 Derkay CS, Hester RP, Burke B. et al. Analysis of a staging assessment system for prediction of surgical interval in recurrent respiratory papillomatosis. Int J Pediatr Otorhinolaryngol 2004; 68: 1493-1498
87 Ivancic R, Iqbal H, deSilva B. et al. Current and future management of recurrent respiratory papillomatosis. Laryngoscope Investig Otolaryngol 2018; 3: 22-34
88 Langer C, Wittekindt C, Wolf G. Laryngeal Recurrent Respiratory Papillomatosis: Current Aspects on Diagnosis and Therapy. Laryngorhinootologie 2019; 98: 577-587
89 Dubey SP, Banerjee S, Ghosh LM. et al. Benign pleomorphic adenoma of the larynx: report of a case and review and analysis of 20 additional cases in the literature. Ear Nose Throat J 1997; 76: 548-550 552, 554-547
90 Kovarik J, Milne D, Robinson M. et al. Primary carcinoma ex-pleomorphic adenoma of anterior commissure of the larynx. Oral Oncol 2018; 84: 131-133
91 Milford CA, Mugliston TA, O’Flynn P. et al. Carcinoma arising in a pleomorphic adenoma of the epiglottis. J Laryngol Otol 1989; 103: 324-327
92 Ito A, Sone M, Kitamura Y. et al. A case of pleomorphic adenoma of the epiglottis. Bilateral vocal-cord paralysis after YAG laser surgery. Auris Nasus Larynx 1997; 24: 303-307
93 Pardal Refoyo JL, Gonzalez del Rey MC, Ursua Sarmiento I. et al. Subglottic pleomorphic adenoma. An Otorrinolaringol Ibero Am 2001; 28: 129-137
94 Sim DW, Oh IJ, Kim KS. et al. Pleomorphic adenoma of the trachea. J Bronchology Interv Pulmonol 2014; 21: 230-233
95 Motahari SJ, Khavarinejad F, Salimi S. et al. Pleomorphic Adenoma of the Larynx: A Case Report. Iran J Otorhinolaryngol 2016; 28: 73-77
96 Argat M, Born IA, Maier H. et al. Pleomorphic adenoma of the larynx. Eur Arch Otorhinolaryngol 1994; 251: 304-306
97 Altunpulluk MD, Karabulut MH, Kir G. et al. Pleomorphic adenoma of the larynx. North Clin Istanb 2016; 3: 67-70
98 Suttner HJ, Stoss H, Iro H. Pleomorphic adenoma of the epiglottis. Case report and review of the literature. HNO 1992; 40: 453-455
99 Ozlugedik S, Tuncel U, Han U. et al. Laryngeal chondroma: a rare neck tumor in pediatric age. Int J Pediatr Otorhi 2004; 68: 1551-1555
100 Gokdogan O, Koybasioglu A, Ileri F. Laryngeal Chondroma: An Unusual Complication Endotracheal Entubation. Journal of Craniofacial Surgery 2016; 27: 1007-1009
101 Franco RA, Singh B, Har-El G. Laryngeal chondroma. Journal of Voice 2002; 16: 92-95
102 Tastekin E, Altaner S, Uzun C. et al. Laryngeal chondroma: a rare diagnosis in this localization. Case Rep Pathol 2011; 2011: 852396
103 Lai YT, Petty BE, Huang W. et al. Bilateral Vocal Fold Chondromas. Journal of Voice 2013; 27: 255-257
104 Yang SW, Lin CY. A peculiar site of chondroma: The epiglottis. Acta Oto-Laryngol 2005; 125: 906-909
105 Ozcan I, Ozcan KM, Selcuk A. et al. Hyoid chondroma presenting as an external neck mass. Journal of Craniofacial Surgery 2007; 18: 1184-1187
106 Gundlach P, Radke C, Waldschmidt J. Congenital laryngeal chondroma: an unusual cause of congenital stridor. Z Kinderchir 1990; 45: 182-184
107 Gulden JW, Straehler-Pohl HJ. Chondroma of the larynx--case report and differential diagnosis in CT. Bildgebung 1990; 57: 90-92
108 Tan Z, Yao M, Liu T. et al. Chondroma of laryngeal cartilage mimicking thyroid tumor: A case report. Medicine (Baltimore) 2019; 98: e15005
109 Baatenburg de Jong RJ, van Lent S, Hogendoorn PC. Chondroma and chondrosarcoma of the larynx. Curr Opin Otolaryngol Head Neck Surg 2004; 12: 98-105
110 Chiu LD, Rasgon BM. Laryngeal chondroma: a benign process with long-term clinical implications. Ear Nose Throat J 1996; 75: 540-542 544-549
111 Verhulst J, Gal M, Carles D. et al. Chondroma and chondrosarcoma of the larynx: apropos of 4 cases. Rev Laryngol Otol Rhinol (Bord) 1996; 117: 183-188
112 Azandaryani AR, Eftekharian M, Taghipour M. Large Laryngeal Lipoma with Extra Laryngeal Component Mimics Mixed Form Laryngocele: A Case Report. Adv J Emerg Med 2019; 3: e45
113 Khorsandi Ashtiani MT, Yazdani N, Saeedi M. et al. Large lipoma of the larynx: a case report. Acta Med Iran 2010; 48: 353-356
114 Okromelidze L, Middlebrooks EH, Bhatt AA. Lipoma of the Larynx and Other Differential Diagnoses. J Clin Imaging Sci 2019; 9: 51
115 Costa NR, Duarte D, Viana M. Lipoma of the pre-epiglottic space: A common pathology in an uncommon place. Acta Otorrinolaringol Esp 2018; 69: 181-182
116 Durr ML, Agrawal N, Saunders JR. et al. Laryngeal lipoma associated with diffuse lipomatosis: case report and literature review. Ear Nose Throat J 2010; 89: 34-37
117 Burkes JN, Campos L, Williams FC. et al. Laryngeal Spindle Cell/Pleomorphic Lipoma: A Case Report. An In-Depth Review of the Adipocytic Tumors. J Oral Maxillofac Surg 2019; 77: 1401-1410
118 Wolf-Magele A, Schnabl J, Url C. et al. Acute dyspnea caused by a giant spindle cell lipoma of the larynx. Wien Klin Wochenschr 2016; 128: 146-149
119 Kodiyan J, Rudman JR, Rosow DE. et al. Lipoma and liposarcoma of the larynx: case reports and literature review. Am J Otolaryngol 2015; 36: 611-615
120 D’Antonio A, Mottola G, Caleo A. et al. Spindle cell lipoma of the larynx. Ear Nose Throat J 2013; 92: E9
121 Nonaka S, Enomoto K, Kawabori S. et al. Spindle cell lipoma within the larynx: a case report with correlated light and electron microscopy. ORL J Otorhinolaryngol Relat Spec 1993; 55: 147-149
122 Charpentier A, Thiesler T, Bartmann D. et al. [Slowly progressive dysphonia]. HNO 2019; 67: 952-954
123 De Vincentiis M, Greco A, Mascelli A. et al. Lipoma of the larynx: a case report. Acta Otorhinolaryngol Ital 2010; 30: 58-63
124 Sharma SJ, Kreisel M, Kroll T. et al. Extracardiac juvenile rhabdomyoma of the larynx: a rare pathological finding. Eur Arch Otorhinolaryngol 2013; 270: 773-776
125 Altissimi G, Ralli M, Sementilli G. et al. Adult-Type Rhabdomyoma of the Larynx: Clinicopathologic Study of an Uncommon Tumor in a Rare Location. Case Rep Otolaryngol 2017; 2017: 7186768
126 Balakumar R, Farr MRB, Fernando M. et al. Adult-Type Rhabdomyoma of the Larynx in Birt-Hogg-Dube Syndrome: Evidence for a Real Association. Head Neck Pathol 2019; 13: 507-511
127 Elawabdeh N, Sobol S, Blount AC. et al. Unusual presentation of extracardiac fetal rhabdomyoma of the larynx in a pediatric patient with tuberous sclerosis. Fetal Pediatr Pathol 2013; 31: 43-47
128 Johansen EC, Illum P. Rhabdomyoma of the larynx: a review of the literature with a summary of previously described cases of rhabdomyoma of the larynx and a report of a new case. J Laryngol Otol 1995; 109: 147-153
129 Hansen T, Katenkamp D. Rhabdomyoma of the head and neck: morphology and differential diagnosis. Virchows Arch 2005; 447: 849-854
130 Hamper K, Renninghoff J, Schafer H. Rhabdomyoma of the larynx recurring after 12 years: immunocytochemistry and differential diagnosis. Arch Otorhinolaryngol 1989; 246: 222-226
131 Sankar G, Rajaraman V, Ganesh RN. et al. Multiple Cutaneous Metastases on (99m)TC-HYNIC-TOC Scan in a Rare Case of Malignant Laryngeal Paraganglioma. Indian J Nucl Med 2018; 33: 348-350
132 Rubin AD, Cheng SS, Bradford CR. Laryngeal paraganglioma in a patient with multiple head and neck paragangliomas. Otolaryngol Head Neck Surg 2005; 132: 520-522
133 Williams MD. Paragangliomas of the Head and Neck: An Overview from Diagnosis to Genetics. Head Neck Pathol 2017; 11: 278-287
134 Piccini V, Rapizzi E, Bacca A. et al. Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients. Endocr Relat Cancer 2012; 19: 149-155
135 Schiavi F, Boedeker CC, Bausch B. et al. Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene. JAMA 2005; 294: 2057-2063
136 Naik SM, Shenoy AM, Chavan P. et al. Laryngeal paraganglioma: a rare clinical entity managed by supraselective embolization and lateral pharygotomy. Indian J Otolaryngol Head Neck Surg 2013; 65: 95-104
137 Sesterhenn AM, Folz BJ, Lippert BM. et al. Laser surgical treatment of laryngeal paraganglioma. J Laryngol Otol 2003; 117: 641-646
138 Smolarz JR, Hanna EY, Williams MD. et al. Paraganglioma of the endolarynx: a rare tumor in an uncommon location. Head Neck Oncol 2010; 2: 2
139 Papacharalampous GX, Chrysovergis AI, Tsiambas E. et al. Laryngeal paragangliomas – controversies in diagnosis and management. J BUON 2009; 14: 405-409
140 Pellitteri PK, Rinaldo A, Myssiorek D. et al. Paragangliomas of the head and neck. Oral Oncol 2004; 40: 563-575
141 Rognone E, Rossi A, Conte M. et al. Laryngeal schwannoma in an 8-year-old boy with inspiratory dyspnea. Head Neck 2007; 29: 972-975
142 Wong BLK, Bathala S, Grant D. Laryngeal schwannoma: a systematic review. Eur Arch Otorhinolaryngol 2017; 274: 25-34
143 Romak JJ, Neel HB, Ekbom DC. Laryngeal Schwannoma: A Case Presentation and Review of the Mayo Clinic Experience. J Voice 2017; 31: 129 e115-129 e118
144 Ebmeyer J, Reineke U, Gehl HB. et al. Schwannoma of the larynx. Head Neck Oncol 2009; 1: 24
145 Ayad JB, Nekro C, Rokhssi S. et al. An unusual cause of high dysphagia: schwannoma of the preepiglottic space. Pan Afr Med J 2017; 28: 295
146 Tulli M, Bondi S, Bussi M. Voluminous laryngeal schwannoma excision with a mini-invasive external approach: a case report. Acta Otorhinolaryngol Ital 2017; 37: 242-244
147 Millas T, Granell J, Garrido L. et al. Transoral robotic approach for laryngeal schwannoma. Head Neck 2015; 37: E70-E73
148 Liu J, Wong CF, Lim F. et al. Glottic neurofibroma in an elderly patient: a case report. J Voice 2013; 27: 644-646
149 Dave SP, Farooq U, Civantos FJ. Management of advanced laryngeal and hypopharyngeal plexiform neurofibroma in adults. Am J Otolaryngol 2008; 29: 279-283
150 Mobashir MK, Mohamed AE, El-Anwar MW. et al. Massive Plexiform Neurofibroma of the Neck and Larynx. Int Arch Otorhinolaryngol 2015; 19: 349-353
151 Gstottner M, Galvan O, Gschwendtner A. et al. Solitary subglottic neurofibroma: a report of an unusual manifestation. Eur Arch Otorhinolaryngol 2005; 262: 705-707
152 Nakahira M, Nakatani H, Sawada S. et al. Neurofibroma of the larynx in neurofibromatosis: preoperative computed tomography and magnetic resonance imaging. Arch Otolaryngol Head Neck Surg 2001; 127: 325-328
153 Friedrich RE, Korf B, Funsterer C. et al. Growth type of plexiform neurofibromas in NF1 determined on magnetic resonance images. Anticancer Res 2003; 23: 949-952
154 Chinn SB, Collar RM, McHugh JB. et al. Pediatric laryngeal neurofibroma: case report and review of the literature. Int J Pediatr Otorhinolaryngol 2014; 78: 142-147
155 Rahbar R, Litrovnik BG, Vargas SO. et al. The biology and management of laryngeal neurofibroma. Arch Otolaryngol 2004; 130: 1400-1406
156 Nolte E, Kleinsasser O. Granular-Cell Tumors of the Larynx. Hno 1982; 30: 333-339
157 Gonik NJ, Zeltsman D, Smith LP. Complicated pediatric subglottic granular cell tumor with extensive intraluminal and extraluminal invasion. Int J Pediatr Otorhi 2014; 78: 1563-1565
158 Valldeperes A, Thomas-Arrizabalaga I, Alvarez-Ceballos L. et al. Granular Cell Tumors of the Larynx: A Clinicopathologic Study of Five Patients. J Voice. 2019
159 Reiter R, Ruess J, Brosch S. et al. Refractory Therapy Hoarseness in Granular Cell Tumor of the Vocal Cord. Laryngo Rhino Otol 2016; 95: 125-126
160 McIntyre CJ, Allen JL, Powell H. et al. Novel surgical management of a laryngeal granular cell tumour. BMJ Case Rep 2015; 2015
161 Sproat R, Wong G, Rubin J. Granular Cell Tumour of the Larynx. Head Neck Pathol 2016; 10: 538-540
162 Park JH, Do NY, Cho SI. et al. Granular cell tumor on larynx. Clin Exp Otorhinolaryngol 2010; 3: 52-55
163 Gonik NJ, Zeltsman D, Smith LP. Complicated pediatric subglottic granular cell tumor with extensive intraluminal and extraluminal invasion. Int J Pediatr Otorhinolaryngol 2014; 78: 1563-1565
164 Conley SF, Milbrath MM, Beste DJ. Pediatric Laryngeal Granular-Cell Tumor. J Otolaryngol 1992; 21: 450-453
165 Ting M, Roseby R, McAdam C. Subglottic infantile haemangioma: A rare but important consideration in young infants presenting with stridor. J Paediatr Child Health 2016; 52: 1111-1113
166 Heyduck A, Pickhard A, Brosch S. et al. [Subglottic pathologies]. Laryngorhinootologie 2019; 98: 461-472
167 Darrow DH. Management of Infantile Hemangiomas of the Airway. Otolaryngol Clin North Am 2018; 51: 133-146
168 Mulliken JB, Fishman SJ, Burrows PE. Vascular anomalies. Curr Probl Surg 2000; 37: 517-584
169 Schwartz T, Faria J, Pawar S. et al. Efficacy and rebound rates in propranolol-treated subglottic hemangioma: A literature review. Laryngoscope 2017; 127: 2665-2672
170 Rahbar R, Nicollas R, Roger G. et al. The biology and management of subglottic hemangioma: Past, present, future. Laryngoscope 2004; 114: 1880-1891
171 Nocini R, Molteni G, Mattiuzzi C. et al. Updates on larynx cancer epidemiology. Chin J Cancer Res 2020; 32: 18-25
172 Lopez F, Williams MD, Cardesa A. et al. How phenotype guides management of non-conventional squamous cell carcinomas of the larynx?. Eur Arch Oto-Rhino-L 2017; 274: 2709-2726
173 Lovato A, Staffieri A, Marino F. et al. Immunohistochemical and HPV-related features of laryngeal adenosquamous carcinoma. Am J Otolaryng 2015; 36: 442-445
174 Thompson L. World Health Organization classification of tumours: pathology and genetics of head and neck tumours. Ear Nose Throat J 2006; 85: 74
175 Dubal PM, Unsal AA, Echanique KA. et al. Laryngeal adenosquamous carcinoma: A population-based perspective. Laryngoscope 2016; 126: 858-863
176 Keelawat S, Liu CZ, Roehm PC. et al. Adenosquamous carcinoma of the upper aerodigestive tract: a clinicopathologic study of 12 cases and review of the literature. Am J Otolaryngol 2002; 23: 160-168
177 Kusafuka K, Muramatsu K, Iida Y. et al. MUC expression in adenosquamous carcinoma of the head and neck regions of Japanese patients: immunohistochemical analysis. Pathol Int 2014; 64: 104-114
178 Yoshimura Y, Mishima K, Obara S. et al. Clinical characteristics of oral adenosquamous carcinoma: report of a case and an analysis of the reported Japanese cases. Oral Oncol 2003; 39: 309-315
179 Marioni G, Mariuzzi L, Gaio E. et al. Lymphoepithelial carcinoma of the larynx. Acta Oto-Laryngol 2002; 122: 429-434
180 Kermani W, Belcadhi M, Sriha B. et al. Epstein-Barr virus-associated lymphoepithelial carcinoma of the larynx. Eur Ann Otorhinolary 2015; 132: 231-233
181 Andryk J, Freije JE, Schultz CJ. et al. Lymphoepithelioma of the larynx. Am J Otolaryng 1996; 17: 61-63
182 MacMillan C, Kapadia SB, Finkelstein SD. et al. Lymphoepithelial carcinoma of the larynx and hypopharynx: Study of eight cases with relationship to Epstein-Barr virus and p53 gene alterations, and review of the literature. Hum Pathol 1996; 27: 1172-1179
183 Coskun BU, Cinar U, Sener BM. et al. Lymphoepithelial carcinoma of the larynx. Auris Nasus Larynx 2005; 32: 189-193
184 Sone M, Nakashima T, Nagasaka T. et al. Lymphoepithelioma-like carcinoma of the larynx associated with an Epstein-Barr viral infection. Otolaryng Head Neck 1998; 119: 134-137
185 Iezzoni JC, Gaffey MJ, Weiss LM. The Role of Epstein-Barr-Virus in Lymphoepithelioma-Like Carcinomas. American Journal of Clinical Pathology 1995; 103: 308-315
186 Coskun BU, Cinar U, Sener BM. et al. Lymphoepithelial carcinoma of the larynx. Auris Nasus Larynx 2005; 32: 189-193
187 Marioni G, Mariuzzi L, Gaio E. et al. Lymphoepithelial carcinoma of the larynx. Acta Otolaryngol 2002; 122: 429-434
188 Ibrahimov M, Yilmaz M, Celal MH. et al. Lymphoepithelial carcinoma of the larynx. J Craniofac Surg 2013; 24: 1049
189 Ferlito A, Weiss LM, Rinaldo A. et al. Clinicopathological consultation. Lymphoepithelial carcinoma of the larynx hypopharynx, and trachea. Ann Otol Rhinol Laryngol 1997; 106: 437-444
190 Testa D, Guerra G, Conzo G. et al. Glottic-Subglottic adenoid cystic carcinoma. A case report and review of the literature. BMC Surg 2013; 13: S48
191 Jones AV, Craig GT, Speight PM. et al. The range and demographics of salivary gland tumours diagnosed in a UK population. Oral Oncol 2008; 44: 407-417
192 Dubal PM, Svider PF, Folbe AJ. et al. Laryngeal adenoid cystic carcinoma: A population-based perspective. Laryngoscope 2015; 125: 2485-2490
193 Batsakis JG, Luna MA, el-Naggar AK. Nonsquamous carcinomas of the larynx. Ann Otol Rhinol Laryngol 1992; 101: 1024-1026
194 Ganly I, Patel SG, Coleman M. et al. Malignant minor salivary gland tumors of the larynx. Arch Otolaryngol Head Neck Surg 2006; 132: 767-770
195 Del Negro A, Ichihara E, Tincani AJ. et al. Laryngeal adenoid cystic carcinoma: case report. Sao Paulo Med J 2007; 125: 295-296
196 Idowu MO, Reiter ER, Powers CN. Adenoid cystic carcinoma: a pitfall in aspiration cytology of the thyroid. Am J Clin Pathol 2004; 121: 551-556
197 Brill LB, Kanner WA, Fehr A. et al. Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms. Mod Pathol 2011; 24: 1169-1176
198 Saraydaroglu O, Coskun H, Kasap M. Unique presentation of adenoid cystic carcinoma in postcricoid region: a case report and review of the literature. Head Neck Pathol 2011; 5: 413-415
199 Liu W, Chen X. Adenoid cystic carcinoma of the larynx: a report of six cases with review of the literature. Acta Otolaryngol 2015; 135: 489-493
200 Avery CM, Moody AB, McKinna FE. et al. Combined treatment of adenoid cystic carcinoma of the salivary glands. Int J Oral Maxillofac Surg 2000; 29: 277-279
201 Fordice J, Kershaw C, El-Naggar A. et al. Adenoid cystic carcinoma of the head and neck: predictors of morbidity and mortality. Arch Otolaryngol Head Neck Surg 1999; 125: 149-152
202 Garden AS, Weber RS, Morrison WH. et al. The influence of positive margins and nerve invasion in adenoid cystic carcinoma of the head and neck treated with surgery and radiation. Int J Radiat Oncol Biol Phys 1995; 32: 619-626
203 Chen AM, Bucci MK, Weinberg V. et al. Adenoid cystic carcinoma of the head and neck treated by surgery with or without postoperative radiation therapy: prognostic features of recurrence. Int J Radiat Oncol Biol Phys 2006; 66: 152-159
204 Lang K, Baur M, Akbaba S. et al. Intensity Modulated Radiotherapy (IMRT)+Carbon Ion Boost for Adenoid Cystic Carcinoma of the Minor Salivary Glands in the Oral Cavity. Cancers (Basel) 2018; 10
205 Kokemueller H, Eckardt A, Brachvogel P. et al. Adenoid cystic carcinoma of the head and neck--a 20 years experience. Int J Oral Maxillofac Surg 2004; 33: 25-31
206 Alavi S, Namazie A, Calcaterra TC. et al. Glandular carcinoma of the larynx: the UCLA experience. Ann Otol Rhinol Laryngol 1999; 108: 485-489
207 Mahlstedt K, Ussmuller J, Donath K. Malignant sialogenic tumours of the larynx. J Laryngol Otol 2002; 116: 119-122
208 Cohen J, Guillamondegui OM, Batsakis JG. et al. Cancer of the Minor Salivary-Glands of the Larynx. Am J Surg 1985; 150: 513-518
209 Prgomet D, Bilic M, Bumber Z. et al. Mucoepidermoid carcinoma of the larynx: report of three cases. Journal of Laryngology and Otology 2003; 117: 998-1000
210 Bhagat S, Varshney S, Singh RK. et al. Mucoepidermoid carcinoma of the larynx with transglottic involvement in a child: A case report. Ent-Ear Nose Throat 2012; 91: 533-535
211 Kleinsasser O. Tumors of the larynx and hypopharynx. Thieme Publishing Group; 1988
212 Ferlito A, Recher G, Bottin R. Mucoepidermoid Carcinoma of the Larynx – a Clinicopathological Study of 11 Cases with Review of the Literature. Orl J Oto-Rhino-Lary 1981; 43: 280-299
213 King W, Ko S, Miller D. Recurrent High-Grade Invasive Mucoepidermoid Carcinoma of Larynx: A Case Report and Review of the Literature. Rare Tumors 2016; 8: 6204
214 Gale N, Poljak M, Zidar N. Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: What is New in the 2017 WHO Blue Book for Tumours of the Hypopharynx, Larynx, Trachea and Parapharyngeal Space. Head Neck Pathol 2017; 11: 23-32
215 van der Laan TP, Plaat BE, van der Laan BF. et al. Clinical recommendations on the treatment of neuroendocrine carcinoma of the larynx: A meta-analysis of 436 reported cases. Head Neck 2015; 37: 707-715
216 Ferlito A, Rinaldo A, Bishop JA. et al. Paraneoplastic syndromes in patients with laryngeal neuroendocrine carcinomas: clinical manifestations and prognostic significance. Eur Arch Otorhinolaryngol 2016; 273: 533-536
217 Chung JH, Lee SS, Shim YS. et al. A study of moderately differentiated neuroendocrine carcinomas of the larynx and an examination of non-neoplastic larynx tissue for neuroendocrine cells. Laryngoscope 2004; 114: 1264-1270
218 Feola T, Puliani G, Sesti F. et al. Laryngeal Neuroendocrine Tumor With Elevated Serum Calcitonin: A Diagnostic and Therapeutic Challenge. Case Report and Review of Literature. Front Endocrinol (Lausanne) 2020; 11: 397
219 Machens A, Holzhausen HJ, Dralle H. Minimally invasive surgery for recurrent neuroendocrine carcinoma of the supraglottic larynx. Eur Arch Otorhinolaryngol 1999; 256: 242-246
220 Jadhav S, Basu S. Metastatic large cell neuroendocrine carcinoma of larynx: Individualizing tumor biology by dual tracer positron emission tomography/computed tomography ((68)Ga-DOTATATE and (18)F-fluorodeoxyglucose) molecular imaging and disease stabilization following (177)Lu-DOTATATE peptide receptor radionuclide therapy after initial progression on chemoradiotherapy. World J Nucl Med 2019; 18: 431-433
221 Ferlito A, Silver CE, Bradford CR. et al. Neuroendocrine neoplasms of the larynx: an overview. Head Neck 2009; 31: 1634-1646
222 Kraus DH, Dubner S, Harrison LB. et al. Prognostic factors for recurrence and survival in head and neck soft tissue sarcomas. Cancer 1994; 74: 697-702
223 Le Vay J, O’Sullivan B, Catton C. et al. An assessment of prognostic factors in soft-tissue sarcoma of the head and neck. Arch Otolaryngol Head Neck Surg 1994; 120: 981-986
224 Pellitteri PK, Ferlito A, Bradley PJ. et al. Management of sarcomas of the head and neck in adults. Oral Oncol 2003; 39: 2-12
225 Dubal PM, Svider PF, Kanumuri VV. et al. Laryngeal chondrosarcoma: a population-based analysis. Laryngoscope 2014; 124: 1877-1881
226 Oliveira JF, Branquinho FA, Monteiro AR. et al. Laryngeal chondrosarcoma--ten years of experience. Braz J Otorhinolaryngol 2014; 80: 354-358
227 Buda I, Hod R, Feinmesser R. et al. Chondrosarcoma of the larynx. Isr Med Assoc J 2012; 14: 681-684
228 Merrot O, Gleizal A, Poupart M. et al. Cartilaginous tumors of the larynx: endoscopic laser management using YAG/KTP. Head Neck 2009; 31: 145-152
229 Damiani V, Crosetti E, Rizzotto G. et al. Well and intermediate differentiated laryngeal chondrosarcoma: toward conservative surgery?. Eur Arch Otorhinolaryngol 2014; 271: 337-344
230 Gripp S, Pape H, Schmitt G. Chondrosarcoma of the larynx: the role of radiotherapy revisited--a case report and review of the literature. Cancer 1998; 82: 108-115
231 Hicks J, Flaitz C. Rhabdomyosarcoma of the head and neck in children. Oral Oncol 2002; 38: 450-459
232 Qualman SJ, Coffin CM, Newton WA. et al. Intergroup Rhabdomyosarcoma Study: update for pathologists. Pediatr Dev Pathol 1998; 1: 550-561
233 Biegel JA, Nycum LM, Valentine V. et al. Detection of the t(2;13)(q35;q14) and PAX3-FKHR fusion in alveolar rhabdomyosarcoma by fluorescence in situ hybridization. Genes Chromosomes Cancer 1995; 12: 186-192
234 Maheshwari GK, Baboo HA, Gopal U. et al. Primary rhabdomyosarcoma of the larynx. Indian J Otolaryngol Head Neck Surg 2004; 56: 138-141
235 Reiter R, Brosch S, Smith E. et al. Manifestation of Rheumatic Diseases in the Larynx. Laryngo Rhino Otol 2015; 94: 189-195
236 Speyer R, Speyer I, Heijnen MAM. Prevalence and relative risk of dysphonia in rheumatoid arthritis. Journal of Voice 2008; 22: 232-237
237 Fisher BA, Dolan K, Hastings L. et al. Prevalence of subjective voice impairment in rheumatoid arthritis. Clin Rheumatol 2008; 27: 1441-1443
238 Roy N, Tanner K, Merrill RM. et al. Descriptive Epidemiology of Voice Disorders in Rheumatoid Arthritis: Prevalence, Risk Factors, and Quality of Life Burden. J Voice 2016; 30: 74-87
239 Pradhan P, Bhardwaj A, Venkatachalam VP. Bilateral Cricoarytenoid Arthritis: A Cause of Recurrent Upper Airway Obstruction in Rheumatoid Arthritis. Malays J Med Sci 2016; 23: 89-91
240 Murano E, Hosako-Naito Y, Tayama N. et al. Bamboo node: Primary vocal fold lesion as evidence of autoimmune disease. Journal of Voice 2001; 15: 441-450
241 Beirith SC, Ikino CMY, Pereira IA. Laryngeal involvement in rheumatoid arthritis. Braz J Otorhinolar 2013; 79: 233-238
242 Loukili NH, Pettorin C, Noel E. et al. Type 1 autoimmune hepatitis revealed by a dysphonia related to cricoarytenoid arthritis. QJM 2003; 96: 171-172
243 Seve P, Poupart M, Bui-Xuan C. et al. Cricoarytenoid arthritis in Sjogren’s syndrome. Rheumatology International 2005; 25: 301-302
244 Nanke Y, Kotake S, Yonemoto K. et al. Cricoarytenoid arthritis with rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol 2001; 28: 624-626
245 Habib MA. Intra-articular steroid injection in acute rheumatoid arthritis of the larynx. J Laryngol Otol 1977; 91: 909-910
246 Kerstens PJ, Boerbooms AM, Jeurissen ME. et al. Accelerated nodulosis during low dose methotrexate therapy for rheumatoid arthritis. An analysis of ten cases. J Rheumatol 1992; 19: 867-871
247 Lanks CW, Van Natta TL, Hsia DW. Primary Laryngotracheal Amyloidosis With Bilateral Vocal Cord Involvement and Associated Bronchiectasis. J Bronchology Interv Pulmonol 2016; 23: 347-349
248 Ma L, Bandarchi B, Sasaki C. et al. Primary localized laryngeal amyloidosis: report of 3 cases with long-term follow-up and review of the literature. Arch Pathol Lab Med 2005; 129: 215-218
249 Ding L, Li W, Wang K. et al. Primary tracheobronchial amyloidosis in China: analysis of 64 cases and a review of literature. J Huazhong Univ Sci Technolog Med Sci 2010; 30: 599-603
250 Yakupova EI, Bobyleva LG, Vikhlyantsev IM. et al. Congo Red and amyloids: history and relationship. Bioscience Rep 2019; 39
251 Piazza C, Cavaliere S, Foccoli P. et al. Endoscopic management of laryngo-tracheobronchial amyloidosis: a series of 32 patients. Eur Arch Oto-Rhino-L 2003; 260: 349-354
252 Monroe AT, Walia R, Zlotecki RA. et al. Tracheobronchial amyloidosis: a case report of successful treatment with external beam radiation therapy. Chest 2004; 125: 784-789
253 Salato VK, Hacker-Foegen MK, Lazarova Z. et al. Role of intramolecular epitope spreading in pemphigus vulgaris. Clin Immunol 2005; 116: 54-64
254 Mahoney MG, Wang Z, Rothenberger K. et al. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. J Clin Invest 1999; 103: 461-468
255 Komai A, Amagai M, Ishii K. et al. The clinical transition between pemphigus foliaceus and pemphigus vulgaris correlates well with the changes in autoantibody profile assessed by an enzyme-linked immunosorbent assay. Brit J Dermatol 2001; 144: 1177-1182
256 Schmidt E, Goebeler M, Zillikens D. Rituximab in Severe Pemphigus. Ann Ny Acad Sci 2009; 1173: 683-691
257 Lee J, Lundgren DK, Mao X. et al. Antigen-specific B-cell depletion for precision therapy of mucosal pemphigus vulgaris. J Clin Invest. 2020
258 Ellebrecht CT, Bhoj VG, Nace A. et al. Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease. Science 2016; 353: 179-184
259 Wojciechowska J, Krajewski W, Krajewski P. et al. Granulomatosis With Polyangiitis in Otolaryngologist Practice: A Review of Current Knowledge. Clin Exp Otorhinolar 2016; 9: 8-13
260 Alam DS, Seth R, Sindwani R. et al. Upper airway manifestations of granulomatosis with polyangiitis. Cleve Clin J Med 2012; 79: S16-S21
261 Belloso A, Estrach C, Keith AO. Supraglottic stenosis in localized Wegener granulomatosis. Ear Nose Throat J 2008; 87: E11-E14
262 Radic M, Kaliterna DM, Radic J. Drug-induced vasculitis: a clinical and pathological review. Neth J Med 2012; 70: 12-17
263 Leavitt RY, Fauci AS, Bloch DA. et al. The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum 1990; 33: 1101-1107
264 Holle JU, Gross WL, Holl-Ulrich K. et al. Prospective long-term follow-up of patients with localised Wegener’s granulomatosis: does it occur as persistent disease stage?. Ann Rheum Dis 2010; 69: 1934-1939
265 Trimarchi M, Sinico RA, Teggi R. et al. Otorhinolaryngological manifestations in granulomatosis with polyangiitis (Wegener’s). Autoimmunity Reviews 2013; 12: 501-505
266 Smith E, Reiter R, Lindemann J. et al. Dysphonia as a Symptom of Sarcoidosis. Laryngo Rhino Otol 2014; 93: 115-116
267 Wu TJ, Lewis SM, Woo P. Neurosarcoidosis Presenting Initially as Idiopathic Vocal Cord Paralysis. Ann Oto Rhinol Laryn 2019; 128: 157-161
268 Strychowsky JE, Vargas SO, Cohen E. et al. Laryngeal sarcoidosis: Presentation and management in the pediatric population. Int J Pediatr Otorhi 2015; 79: 1382-1387
269 Morgenthau AS, Teirstein AS. Sarcoidosis of the upper and lower airways. Expert Rev Resp Med 2011; 5: 823-833
270 Edriss H, Kelley JS, Demke J. et al. Sinonasal and Laryngeal Sarcoidosis-An Uncommon Presentation and Management Challenge. Am J Med Sci 2019; 357: 93-102
271 Pearson CM, Kline HM, Newcomer VD. Relapsing polychondritis. N Engl J Med 1960; 263: 51-58
272 Mathew SD, Battafarano DF, Morris MJ. Relapsing polychondritis in the Department of Defense population and review of the literature. Semin Arthritis Rheum 2012; 42: 70-83
273 Buscatti IM, Giacomin MFA, Silva MFC. et al. Laryngotracheal stenosis requiring emergency tracheostomy as the first manifestation of childhood-relapsing polychondritis. Acta Reumatol Port 2013; 38: 208-211
274 McAdam LP, O’Hanlan MA, Bluestone R. et al. Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine (Baltimore) 1976; 55: 193-215
275 Rafeq S, Trentham D, Ernst A. Pulmonary manifestations of relapsing polychondritis. Clin Chest Med 2010; 31: 513-518
276 Lang B, Rothenfusser A, Lanchbury JS. et al. Susceptibility to Relapsing Polychondritis Is Associated with Hla-Dr4. Arthritis Rheum 1993; 36: 660-664
277 Zeuner M, Straub RH, Rauh G. et al. Relapsing polychondritis: Clinical and immunogenetic analysis of 62 patients. Journal of Rheumatology 1997; 24: 96-101
278 Foidart JM, Martin GR, Abe S. et al. Antibodies to Type-2 Collagen and Circulating Immune-Complexes in Relapsing Polychondritis. Clin Res 1978; 26: A376-A376
279 Hansson AS, Heinegard D, Piette JC. et al. The occurrence of autoantibodies to matrilin 1 reflects a tissue-specific response to cartilage of the respiratory tract in patients with relapsing polychondritis. Arthritis Rheum 2001; 44: 2402-2412
280 Stabler T, Piette JC, Chevalier X. et al. Serum cytokine profiles in relapsing polychondritis suggest monocyte/macrophage activation. Arthritis Rheum 2004; 50: 3663-3667
281 Paulsson M, Heinegard D. Radioimmunoassay of the 148-Kilodalton Cartilage Protein – Distribution of the Protein among Bovine-Tissues. Biochem J 1982; 207: 207-213
282 Spraggs PDR, Tostevin PMJ, Howard DJ. Management of laryngotracheobronchial sequelae and complications of relapsing polychondritis. Laryngoscope 1997; 107: 936-941
283 Trentham DE, Le CH. Relapsing polychondritis. Ann Intern Med 1998; 129: 114-122
284 Dion J, Costedoat-Chalumeau N, Sene D. et al. Relapsing Polychondritis Can Be Characterized by Three Different Clinical Phenotypes: Analysis of a Recent Series of 142 Patients. Arthritis Rheumatol 2016; 68: 2992-3001
285 Frikha F, Bahloul Z. [Destructive chronic arthritis revealing a relapsing polychondritis]. Pan Afr Med J 2014; 17: 59
286 Damiani JM, Levine HL. Relapsing polychondritis--report of ten cases. Laryngoscope 1979; 89: 929-946
287 Michet CJ, McKenna CH, Luthra HS. et al. Relapsing polychondritis. Survival and predictive role of early disease manifestations. Ann Intern Med 1986; 104: 74-78
288 Luthra HS, McKenna CH, Terasaki PI. Lack of association of HLA-A and B locus antigens with relapsing polychondritis. Tissue Antigens 1981; 17: 442-443
289 Shimizu J, Oka H, Yamano Y. et al. Cutaneous manifestations of patients with relapsing polychondritis: an association with extracutaneous complications. Clin Rheumatol 2016; 35: 781-783
290 Greco A, Gallo A, Fusconi M. et al. Cogan’s syndrome: an autoimmune inner ear disease. Autoimmun Rev 2013; 12: 396-400
291 Greco A, Gallo A, Fusconi M. et al. Bell’s palsy and autoimmunity. Autoimmun Rev 2012; 12: 323-328
292 Kent PD, Michet CJ, Luthra HS. Relapsing polychondritis. Curr Opin Rheumatol 2004; 16: 56-61
293 Hennessey JV. Riedel’s Thyroiditis: A Clinical Review. J Clin Endocr Metab 2011; 96: 3031-3041
294 Fatourechi MM, Hay ID, McIver B. et al. Invasive Fibrous Thyroiditis (Riedel Thyroiditis): The Mayo Clinic Experience, 1976-2008. Thyroid 2011; 21: 765-772
295 Ozgen A, Cila A. Riedel’s thyroiditis in multifocal fibrosclerosis: CT and MR imaging findings. Am J Neuroradiol 2000; 21: 320-321
296 Papi G, LiVolsi VA. Current concepts on Riedel thyroiditis. Am J Clin Pathol 2004; 121: S50-S63
297 Remerand G, Boespflug-Tanguy O, Tonduti D. et al. Expanding the phenotypic spectrum of Allan-Herndon-Dudley syndrome in patients with SLC16A2 mutations. Dev Med Child Neurol 2019; 61: 1439-1447
298 Dumitrescu AM, Liao XH, Best TB. et al. A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. Am J Hum Genet 2004; 74: 168-175
299 Pennock GD, Raya TE, Bahl JJ. et al. Cardiac effects of 3,5-diiodothyropropionic acid, a thyroid hormone analog with inotropic selectivity. J Pharmacol Exp Ther 1992; 263: 163-169
300 Moreno M, de Lange P, Lombardi A. et al. Metabolic effects of thyroid hormone derivatives. Thyroid 2008; 18: 239-253
301 Hartley MD, Kirkemo LL, Banerji T. et al. A Thyroid Hormone-Based Strategy for Correcting the Biochemical Abnormality in X-Linked Adrenoleukodystrophy. Endocrinology 2017; 158: 1328-1338
302 Kersseboom S, Horn S, Visser WE. et al. In Vitro and Mouse Studies Supporting Therapeutic Utility of Triiodothyroacetic Acid in MCT8 Deficiency. Mol Endocrinol 2014; 28: 1961-1970
303 Braun D, Schweizer U. Efficient Activation of Pathogenic DeltaPhe501 Mutation in Monocarboxylate Transporter 8 by Chemical and Pharmacological Chaperones. Endocrinology 2015; 156: 4720-4730
304 Braun D, Schweizer U. The Chemical Chaperone Phenylbutyrate Rescues MCT8 Mutations Associated With Milder Phenotypes in Patients With Allan-Herndon-Dudley Syndrome. Endocrinology 2017; 158: 678-691
305 Rastogi MV, LaFranchi SH. Congenital hypothyroidism. Orphanet J Rare Dis 2010; 5
306 Harris KB, Pass KA. Increase in congenital hypothyroidism in New York State and in the United States (vol 91, pg 268, 2007). Mol Genet Metab 2008; 94: 140-140
307 Zhan JY, Qin YF, Zhao ZY. Neonatal screening for congenital hypothyroidism and phenylketonuria in China. World J Pediatr 2009; 5: 136-139
308 Lania A, Persani L, Beck-Peccoz P. Central hypothyroidism. Pituitary 2008; 11: 181-186
309 Wells SA, Asa SL, Dralle H. et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid 2015; 25: 567-610
310 Pacini F, Castagna MG, Brilli L. et al. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2012; 23: vii110-vii119
311 Carlson KM, Dou S, Chi D. et al. Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B. Proc Natl Acad Sci U S A 1994; 91: 1579-1583
312 Mulligan LM, Kwok JB, Healey CS. et al. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 1993; 363: 458-460
313 Thomas CM, Asa SL, Ezzat S. et al. Diagnosis and pathologic characteristics of medullary thyroid carcinoma-review of current guidelines. Curr Oncol 2019; 26: 338-344
314 Perros P, Boelaert K, Colley S. et al. Guidelines for the management of thyroid cancer. Clin Endocrinol (Oxf) 2014; 81: 1-122
315 Tuttle RM, Ball DW, Byrd D. et al. Medullary carcinoma. J Natl Compr Canc Netw 2010; 8: 512-530
316 Costante G, Meringolo D, Durante C. et al. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. J Clin Endocrinol Metab 2007; 92: 450-455
317 Biesinger E, Bootz F, Weber B. Life saving glance diagnosis in type IIb multiple endocrine neoplasia. Laryngorhinootologie 1992; 71: 50-52
318 Wells SA, Gosnell JE, Gagel RF. et al. Vandetanib for the treatment of patients with locally advanced or metastatic hereditary medullary thyroid cancer. J Clin Oncol 2010; 28: 767-772
319 Tsang VH, Robinson BG, Learoyd DL. The safety of vandetanib for the treatment of thyroid cancer. Expert Opin Drug Saf 2016; 15: 1107-1113
320 Robinson BG, Paz-Ares L, Krebs A. et al. Vandetanib (100 mg) in patients with locally advanced or metastatic hereditary medullary thyroid cancer. J Clin Endocrinol Metab 2010; 95: 2664-2671
321 Elisei R, Schlumberger MJ, Muller SP. et al. Cabozantinib in progressive medullary thyroid cancer. J Clin Oncol 2013; 31: 3639-3646
322 Sherman SI, Cohen EEW, Schoffski P. et al. Efficacy of cabozantinib (Cabo) in medullary thyroid cancer (MTC) patients with RAS or RET mutations: Results from a phase III study. Journal of Clinical Oncology 2013; 31
323 Larouche V, Akirov A, Thomas CM. et al. A primer on the genetics of medullary thyroid cancer. Curr Oncol 2019; 26: 389-394